Shanghai Medicilon Inc (688202) — Cash Flow Reinvestment Rate

Latest as of June 2022: 17.76x

Shanghai Medicilon Inc (688202) has a Cash Flow Reinvestment Rate of 17.76x as of June 2022, reinvesting CN¥169.63 Million (capex CN¥34.63 Million plus investments CN¥135.00 Million) from operating cash flow of CN¥9.55 Million. Check Shanghai Medicilon Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

17.76x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥169.63 Million
Capex + Investments

Operating Cash Flow

CN¥9.55 Million
CNY

Capital Expenditures

CN¥34.63 Million
CNY

Shanghai Medicilon Inc Cash Flow Reinvestment Rate (2016–2025)

Historical reinvestment intensity for Shanghai Medicilon Inc across 8 annual periods. Explore 688202 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Shanghai Medicilon Inc (2016–2025)

Year-by-year capital reinvestment analysis for Shanghai Medicilon Inc. For live market cap and broader valuation context, see Shanghai Medicilon Inc market cap and net worth.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 2.02x CN¥212.85 Million CN¥105.17 Million CN¥69.03 Million ▼ -94.5%
2023 36.89x CN¥1.23 Billion CN¥33.32 Million CN¥300.10 Million ▲ +4155.0%
2021 0.87x CN¥392.71 Million CN¥452.94 Million CN¥292.71 Million ▼ -5.0%
2020 0.91x CN¥189.61 Million CN¥207.77 Million CN¥118.72 Million ▼ -68.4%
2019 2.89x CN¥168.27 Million CN¥58.30 Million CN¥97.38 Million ▲ +51.7%
2018 1.90x CN¥135.26 Million CN¥71.11 Million CN¥64.37 Million ▲ +9.5%
2017 1.74x CN¥129.80 Million CN¥74.70 Million CN¥58.91 Million ▼ -16.1%
2016 2.07x CN¥70.70 Million CN¥34.13 Million CN¥39.31 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow